MTHFR C677T homozygous as risk factor for complications after OLT for cryptogenic cirrhosis

Clinical Transplantation

Volumn 20, Issue 6, 2006, Pages 796-798

  Pasta, Linda ^a   Marrone, Ciro ^b   D'Amico, Mario ^b   Verdone, Roberto ^a   Rizzo, Aroldo ^a   Sammarco, Piero ^a   Fabiano, Carmelo ^a   Niceta, Marcello ^a   Caltagirone, Maria ^a   D'Amico, Gennaro ^a   Pagliaro, Luigi ^b  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PLASMINOGEN ACTIVATOR INHIBITOR; PREDNISOLONE; PROTHROMBIN; TSUKUBAENOLIDE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BUDD CHIARI SYNDROME; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC RISK; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; METABOLIC DISORDER; PATHOGENESIS; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADULT; BIOPSY; DNA; FEMALE; HOMOZYGOTE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 33750809234     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00564.x     Document Type: Letter

References (6)

1. Duclos-Vallée JC, Yilmaz F, Johanet C et.al. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis ? Clin Transplant 2005: 19: 591.
2. Balta G, Altay C, Gurgey A. PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs. Am J Hematol 2002: 71: 89.
3. Revelo MP, Federspiel C, Helderman H, Fogo AB. Chronic allograft nephropathy: Expression and localization of PAI-1 and PPAR-gamma. Nephrol Dial Transplant 2005: 20: 2812.
4. Adinolfi LE, Ingrosso D, Cesaro G et.al. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology 2005: 41: 995.
5. Heidenreich S, Junker R, Wolters H et.al. Outcome of kidney transplantation in patients with inherited thrombophilia: Data of a prospective study. J Am Soc Nephrol 2003: 14: 234.
6. Akbas SH, Tuncer M, Gurkan A et.al. Plasma homocysteine levels in renal transplant patients on tacrolimus therapy. Transplant Proc 2004: 36: 159.